Sunday , May 16 2021

NCI-MATTERS With AKT1-Mutated Cancer A Good Response to Drugs AstraZeneca



  1. NCI-MATTERS With AKT1-Mutated Cancer Respond well to AstraZeneca Drugs GenomeWeb
  2. Drug-equivalent drugs according to tumor gene tests show signs of effective EurekAlert (press release)
  3. Full broadcast


Source link